Search for a trial | Research with human participants

2 results

Topical Vitamin D3, Diclofenac or a combination of both to treat Basal Cell Carcinoma

Approved WMORecruitment stopped

Primary Objective: To determine whether topical application of Calcitriol (Silkis) 3 µg/g, Diclofenac 10% or a combination of both can lead to a 40% histological reduction (*)/increase (*) of expression of the following antibodies: Ki67 (*), BCL2…

Oral Paricalcitol versus Calcitriol in Peritoneal Dialysis Patients: effects on peritoneal transport and peritoneal defence

Approved WMORecruitment stopped

In this pilot study, we are setting on to investigate the differential effects of the VDR activator paricalcitol versus calcitriol on peritoneal transport, peritoneal inflammation and peritoneal defense parameters in PD patients.